Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masakazu Notsu

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Clinical Calcium|September 4, 2013
[Secondary osteoporosis or secondary contributors to bone loss in fracture. Effects of oxidative stress on bone metabolism]Masakazu Notsu, Toru Yamaguchi
Internal Medicine (Tokyo, Japan)|November 19, 2025
Characteristics of Patients with Primary Hyperparathyroidism with Localization Failure of the Causative Parathyroid Gland: A Clinical Report and Literature ReviewKai Takedani, Masakazu Notsu, Keizo Kanasaki
Endocrine Journal|May 17, 2026
From cross-section to prognosis: risk factors for renal function deterioration in primary hyperparathyroidismTakuma Yamoto, Masakazu Notsu, Keizo Kanasaki
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|September 21, 2020
A pregnant woman with an autonomously functioning thyroid nodule: a case reportMasakazu Notsu, Mika Yamauchi, Toshitsugu Sugimoto, et al.
Diabetes Research and Clinical Practice|June 21, 2016
Visceral fat obesity increases serum DPP-4 levels in men with type 2 diabetes mellitusSayuri Tanaka, Ippei Kanazawa, Masakazu Notsu, et al.
BMC Endocrine Disorders|November 25, 2016
Administration of anti-receptor activator of nuclear factor-kappa B ligand (RANKL) antibody for the treatment of osteoporosis was associated with amelioration of hepatitis in a female patient with growth hormone deficiency: a case reportAyumu Takeno, Masahiro Yamamoto, Masakazu Notsu, et al.
Cureus|September 25, 2023
Progressive Thymic Hyperplasia With Graves' Disease: A Case ReportNoriko Ogawa, Miwako Yomota, Masakazu Notsu, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|December 19, 2018
Higher Serum Uric Acid is a Risk Factor of Vertebral Fractures in Postmenopausal Women with Type 2 Diabetes MellitusKen-Ichiro Tanaka, Ippei Kanazawa, Masakazu Notsu, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|December 13, 2018
Higher Serum Uric Acid is a Risk Factor of Reduced Muscle Mass in Men with Type 2 Diabetes MellitusKen-Ichiro Tanaka, Ippei Kanazawa, Masakazu Notsu, et al.
Journal of Bone and Mineral Metabolism|October 31, 2019
Papillary thyroid carcinoma is a risk factor for severe osteoporosisMasakazu Notsu, Mika Yamauchi, Miwa Morita, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Clinical Calcium|September 4, 2013
[Secondary osteoporosis or secondary contributors to bone loss in fracture. Effects of oxidative stress on bone metabolism]Masakazu Notsu, Toru Yamaguchi
Internal Medicine (Tokyo, Japan)|November 19, 2025
Characteristics of Patients with Primary Hyperparathyroidism with Localization Failure of the Causative Parathyroid Gland: A Clinical Report and Literature ReviewKai Takedani, Masakazu Notsu, Keizo Kanasaki
Endocrine Journal|May 17, 2026
From cross-section to prognosis: risk factors for renal function deterioration in primary hyperparathyroidismTakuma Yamoto, Masakazu Notsu, Keizo Kanasaki
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|September 21, 2020
A pregnant woman with an autonomously functioning thyroid nodule: a case reportMasakazu Notsu, Mika Yamauchi, Toshitsugu Sugimoto, et al.
Diabetes Research and Clinical Practice|June 21, 2016
Visceral fat obesity increases serum DPP-4 levels in men with type 2 diabetes mellitusSayuri Tanaka, Ippei Kanazawa, Masakazu Notsu, et al.
BMC Endocrine Disorders|November 25, 2016
Administration of anti-receptor activator of nuclear factor-kappa B ligand (RANKL) antibody for the treatment of osteoporosis was associated with amelioration of hepatitis in a female patient with growth hormone deficiency: a case reportAyumu Takeno, Masahiro Yamamoto, Masakazu Notsu, et al.
Cureus|September 25, 2023
Progressive Thymic Hyperplasia With Graves' Disease: A Case ReportNoriko Ogawa, Miwako Yomota, Masakazu Notsu, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|December 19, 2018
Higher Serum Uric Acid is a Risk Factor of Vertebral Fractures in Postmenopausal Women with Type 2 Diabetes MellitusKen-Ichiro Tanaka, Ippei Kanazawa, Masakazu Notsu, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|December 13, 2018
Higher Serum Uric Acid is a Risk Factor of Reduced Muscle Mass in Men with Type 2 Diabetes MellitusKen-Ichiro Tanaka, Ippei Kanazawa, Masakazu Notsu, et al.
Journal of Bone and Mineral Metabolism|October 31, 2019
Papillary thyroid carcinoma is a risk factor for severe osteoporosisMasakazu Notsu, Mika Yamauchi, Miwa Morita, et al.
Pageof 5